Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5258]

Nivolumab plus ipilimumab shows better tolerance, effectiveness in metastatic kidney cancer

Nivolumab plus ipilimumab shows better tolerance, effectiveness in metastatic kidney cancer

DNA repair, MACC1 activity determines prognosis and predicts early colon cancer aggressiveness

DNA repair, MACC1 activity determines prognosis and predicts early colon cancer aggressiveness

Fulvestrant receives EU approval as first-line therapy for advanced breast cancer

Fulvestrant receives EU approval as first-line therapy for advanced breast cancer

Four subtypes predict prognosis and response to gastric cancer treatments

Four subtypes predict prognosis and response to gastric cancer treatments

FDA approves test for detection of certain leukaemias and lymphomas

FDA approves test for detection of certain leukaemias and lymphomas

New multidisciplinary approach to identify DNA mutation spectra for carcinogens

New multidisciplinary approach to identify DNA mutation spectra for carcinogens

Positive CHMP opinion for midostaurin for newly diagnosed FLT3-mutated AML, three types of systemic mastocytosis

Positive CHMP opinion for midostaurin for newly diagnosed FLT3-mutated AML, three types of systemic mastocytosis

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

CHMP recommends pembrolizumab approval for select bladder cancers

CHMP recommends pembrolizumab approval for select bladder cancers

Concurrent chemotherapy, proton therapy improves survival in patients with advanced lung cancer

Concurrent chemotherapy, proton therapy improves survival in patients with advanced lung cancer

More from ecancer